Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Weston Nichols currently holds 8,963,500 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Weston Nichols has been a net buyer of CRNX stock. They have purchased $31.6M and sold $0 worth of shares.
Weston Nichols's most recent insider trade was on Oct 28, 2025, when they purchased 165,667 shares at $8.40 per share.
Weston Nichols serves as Executive at Crinetics Pharmaceuticals, Inc. (CRNX). They have executed 8 insider transactions totaling $31.6M over their tenure at the company.
Weston Nichols holds the position of Executive at Crinetics Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Weston Nichols has shown a buying trading pattern, with $31.6M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Weston Nichols was on Dec 26, 2024, when they purchased $30.0M worth of TCRX shares. This transaction involved 7,500,000 shares at $4.00 per share.
Weston Nichols currently owns 8,963,500 shares of Crinetics Pharmaceuticals, Inc. (CRNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Weston Nichols's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Weston Nichols has 8 Form 4 filings on record as an insider at Crinetics Pharmaceuticals, Inc..
Set alerts for Weston Nichols and 40,000+ other insiders.